Jourdan, Eric <br/><br/>
A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma.  [electronic resource] 

 -  Leukemia & lymphoma  Sep 2014 
 - 2013-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2013.861066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Protein Kinase Inhibitors--administration & dosage<br/>Retreatment<br/>Treatment Outcome